Anthony Radford
Direktor/Vorstandsmitglied bei GENETIC SIGNATURES LIMITED
Vermögen: 110 889 $ am 30.04.2024
Aktive Positionen von Anthony Radford
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENETIC SIGNATURES LIMITED | Direktor/Vorstandsmitglied | 15.09.2015 | - |
Karriereverlauf von Anthony Radford
Ehemalige bekannte Positionen von Anthony Radford
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Direktor/Vorstandsmitglied | 07.01.2011 | 01.10.2012 |
Vorstandsvorsitzender | 28.07.2009 | 01.10.2012 | |
Gründer | 01.12.2000 | 01.10.2012 | |
Amrad Operations Pty Ltd. | Corporate Officer/Principal | 01.01.1993 | 01.12.2000 |
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Corporate Officer/Principal | 01.10.1985 | 01.12.1992 |
Ausbildung von Anthony Radford
LaTrobe University | Doctorate Degree |
Statistik
International
Australien | 6 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Commercial Services | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENETIC SIGNATURES LIMITED | Commercial Services |
Private Unternehmen | 3 |
---|---|
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Health Technology |
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Commercial Services |
Amrad Operations Pty Ltd. |
- Börse
- Insiders
- Anthony Radford
- Erfahrung